Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis

Immunobiology

Volumn 215, Issue 11, 2010, Pages 863-873

  Bailón, Elvira ^a   Cueto Sola, Margarita ^a   Utrilla, Pilar ^a   Rodríguez Cabezas, María Elena ^a   Garrido Mesa, Natividad ^a   Zarzuelo, Antonio ^a   Xaus, Jordi ^a   Gálvez, Julio ^a   Comalada, Mònica ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Cytokines; Inflammatory bowel disease; Intestinal mucosa; Lymphocytes; Macrophages; Short chain fatty acids

Indexed keywords

BETA ACTIN; BUTYRIC ACID; CASPASE 3; CASPASE 7; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 5; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL SPECIFICITY; CELL TYPE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENTERITIS; ENZYME ACTIVATION; FETUS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IN VITRO STUDY; INHIBITION KINETICS; INTESTINE EPITHELIUM CELL; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; APOPTOSIS; BUTYRATES; CASPASE 3; CASPASE 7; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITHELIAL CELLS; HT29 CELLS; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MICE; ORGAN SPECIFICITY; T-LYMPHOCYTES;

EID: 77957220072     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.01.001     Document Type: Article

References (61)

1. Amin M.R., Dudeja P.K., Ramaswamy K., Malakooti J. Involvement of Sp1 and Sp3 in differential regulation of human NHE3 promoter activity by sodium butyrate and IFN-gamma/TNF-alpha. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G374-G382.
2. Andoh A., Bamba T., Sasaki M. Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions. J. Parenter. Enteral. Nutr. 1999, 23:S70-S73.
3. Archer S.Y., Johnson J., Kim H.J., Ma Q., Mou H., Daesety V., Meng S., Hodin R.A. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289:G696-G703.
4. Bailón E., Camuesco D., Nieto A., Concha A., Fernández de Arriba A., Román J., Ramis I., Merlos M., Zarzuelo A., Gálvez J., Comalada M. The intestinal anti-inflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition. Biochem. Pharmacol. 2007, 74:1496-1506.
5. Böcker U., Schottelius A., Watson J.M., Holt L., Licato L.L., Brenner D.A., Sartor R.B., Jobin C. Cellular differentiation causes a selective down-regulation of interleukin (IL)-1beta-mediated NF-kappaB activation and IL-8 gene expression in intestinal epithelial cells. J. Biol. Chem. 2000, 275:12207-12213.
6. Böhmig G.A., Krieger P.M., Säemann M.D., Ullrich R., Karimi H., Wekerle T., Mühlbacher F., Zlabinger G.J. Stable prodrugs of n-butyric acid: suppression of T cell alloresponses in vitro and prolongation of heart allograft survival in a fully allogeneic rat strain combination. Transplant Immunol. 1999, 7:221-227.
7. Boirivant M., Marini M., Di Felice G., Pronio A.M., Montesani C., Tersigni R., Strober W. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999, 116:557-565.
8. Butzner J.D., Parmar R., Bell C.J., Dalal V. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 1996, 38:568-573.
9. Cavaglieri C.R., Nishiyama A., Fernandes L.C., Curi R., Miles E.A., Calder P.C. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci. 2003, 73:1683-1690.
10. Comalada M., Valledor A.F., Sanchez-Tilló E., Umbert I., Xaus J., Celada A. Macrophage colony-stimulating factor-dependent macrophage proliferation is mediated through a calcineurin-independent but immunophilin-dependent mechanism that mediates the activation of external regulated kinases. Eur. J. Immunol. 2003, 33:3091-3100.
11. Comalada M., Xaus J., Valledor A.F., López-López C., Pennington D.J., Celada A. PKC epsilon is involved in JNK activation that mediates LPS-induced TNF-alpha, which induces apoptosis in macrophages. Am. J. Physiol. Cell Physiol. 2003, 285:C1235-C1245.
12. Comalada M., Bailón E., de Haro O., Lara-Villoslada F., Xaus J., Zarzuelo A., Gálvez J. The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. J. Cancer Res. Clin. Oncol. 2006, 132:487-497.
13. D'Argenio G., Mazzacca G. Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv. Exp. Med. Biol. 1999, 472:149-158.
14. De Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 2003, 370:737-749.
15. Diakos C., Prieschl E.E., Saemann M., Novotny V., Bohmig G., Csonga R., Baumruker T., Zlabinger G.J. Novel mode of interference with nuclear factor of activated T-cells regulation in T-cells by the bacterial metabolite n-butyrate. J. Biol. Chem. 2002, 277:24243-24251.
16. Feske S., Giltnane J., Dolmetsch R., Staudt L.M., Rao A. Gene regulation mediated by calcium signals in T lymphocytes. Nat. Immunol. 2001, 2:316-324.
17. Fusunyan R.D., Quinn J.J., Ohno Y., MacDermott R.P., Sanderson I.R. Butyrate enhances interleukin (IL)-8 secretion by intestinal epithelial cells in response to IL-1beta and lipopolysaccharide. Pediatr. Res. 1998, 43:84-90.
18. Fusunyan R.D., Quinn J.J., Fujimoto M., MacDermott R.P., Sanderson I.R. Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells through histone acetylation. Mol. Med. 1999, 5:631-640.
19. Gilbert K.M., Wahid R., Fecher N.P., Freeman J.P., Fifer E.K. Potential clinical use of butyric acid derivatives to induce antigen-specific T cell inactivation. J. Pharmacol. Exp. Ther. 2000, 294:1146-1153.
20. Gilbert K.M., Boger S., Fifer E.K. Butyric acid derivative induces allospecific T cell anergy and prevents graft-versus-host disease. Immunopharmacol. Immunotoxicol. 2003, 25:13-27.
21. Han S., Lu J., Zhang Y., Cheng C., Li L., Han L., Huang B. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region. Immunol. Lett. 2007, 108:143-150.
22. Hewinson J., Moore S.F., Glover C., Watts A.G., MacKenzie A.B. A key role for redox signaling in rapid P2×7 receptor-induced IL-1 beta processing in human monocytes. J. Immunol. 2008, 180:8410-8420.
23. Huang N., Katz J.P., Martin D.R., Wu G.D. Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. Cytokine 1997, 9:27-36.
24. Jackson S.K., DeLoose A., Gilbert K.M. The ability of antigen, but not interleukin-2, to promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and altered association patterns of cyclin-dependent kinase inhibitors. Immunology 2002, 106:486-495.
25. Kouraklis G., Theocharis S. Histone deacetylase inhibitors: a novel target of anticancer therapy (review). Oncol. Rep. 2006, 15:489-494.
26. Kurita-Ochiai T., Fukushima K., Ochiai K. Butyric acid-induced apoptosis of murine thymocytes, splenic T cells, and human Jurkat T cells. Infect. Immun. 1997, 65:35-41.
27. Kurita-Ochiai T., Fukushima K., Ochiai K. Lipopolysaccharide stimulates butyric acid-induced apoptosis in human peripheral blood mononuclear cells. Infect. Immun. 1999, 67:22-29.
28. Lin J.X., Leonard W.J. The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites. Mol. Cell Biol. 1997, 17:3714-3722.
29. Lynch D.H., Ramsdell F., Anderson M.R. Fas and FasL in the homeostatic regulation of immune response. Immunol. Today 1995, 16:569-574.
30. Mandal M., Olson D.J., Sharma T., Vadlamudi R.K., Kumar R. Butyric acid induces apoptosis by up-regulating Bax expression via stimulation of the c-Jun N-terminal kinase/activation protein-1 pathway in human colon cancer cells. Gastroenterology 2001, 120:71-78.
31. McBain J.A., Eastman A., Nobel C.S., Mueller G.C. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem. Pharmacol. 1997, 53:1357-1368.
32. Medina V., Edmonds B., Young G.P., James R., Appleton S., Zalewski P.D. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res. 1997, 57:3697-3707.
33. Ohno Y., Lee J., Fusunyan R.D., MacDermott R.P., Sanderson I.R. Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells. Proc. Natl. Acad. Sci. USA 1997, 94:10279-10284.
34. Ortega-Pérez I., Cano E., Were F., Villar M., Vázquez J., Redondo J.M. c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain. J. Biol. Chem. 2005, 280:20867-20878.
35. Paccani S.R., Boncristiano M., Ulivieri C., D'Elios M.M., Del Prete G., Baldari C.T. Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction. J. Biol. Chem. 2002, 277:1509-1513.
36. Park G.Y., Joo M., Pedchenko T., Blackwell T.S., Christman J.W. Regulation of macrophage cyclooxygenase-2 gene expression by modifications of histone H3. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 286:L956-L962.
37. Park J.S., Lee E.J., Lee J.C., Kim W.K., Kim H.S. Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways. Int. Immunopharmacol. 2007, 7:70-77.
38. Rafter J.J. Scientific basis of biomarkers and benefits of functional foods for reduction of disease risk: cancer. Br. J. Nutr. 2002, 2:S219-S224.
39. Ramos M.G., Rabelo F.L., Duarte T., Gazzinelli R.T., Alvarez-Leite J.I. Butyrate induces apoptosis in murine macrophages via caspase-3, but independent of autocrine synthesis of tumor necrosis factor and nitric oxide. Braz. J. Med. Biol. Res. 2002, 35:161-173.
40. Ruemmele F.M., Dionne S., Qureshi I., Sarma D.S., Levy E., Seidman E.G. Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ. 1999, 6:729-735.
41. Säemann M.D., Böhmig G.A., Osterreicher C.H., Burtscher H., Parolini O., Diakos C., Stöckl J., Hörl W.H., Zlabinger G.J. Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J. 2000, 14:2380-2382.
42. Sanderson I.R. Short chain fatty acid regulation of signaling genes expressed by the intestinal epithelium. J. Nutr. 2004, 134:2450S-2454S.
43. Santini V., Gozzini A., Scappini B., Caporale R., Zoccolante A., Rigacci L., Gelardi E., Grossi A., Alterini R., Ferrini P.R. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells. Haematologica 1999, 84:897-904.
44. Sato H., Watanabe A., Tanaka T., Koitabashi N., Arai M., Kurabayashi M., Yokoyama T. Regulation of the human tumor necrosis factor-alpha promoter by angiotensin II and lipopolysaccharide in cardiac fibroblasts: different cis-acting promoter sequences and transcriptional factors. J. Mol. Cell. Cardiol. 2003, 35:1197-1205.
45. Scheppach W., Sommer H., Kirchner T., Paganelli G.M., Bartram P., Christl S., Richter F., Dusel G., Kasper H. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992, 103:51-56.
46. Schumann R.R., Belka C., Reuter D., Lamping N., Kirschning C.J., Weber J.R., Pfeil D. Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. Blood 1998, 91:577-584.
47. Soderberg L.S., Boger S., Fifer E.K., Gilbert K.M. Macrophage production of inflammatory mediators is potently inhibited by a butyric acid derivative demonstrated to inactivate antigen-stimulated T cells. Int. Immunopharmacol. 2004, 4:1231-1237.
48. Steinhart A.H., Hiruki T., Brzezinski A., Baker J.P. Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment. Pharmacol. Ther. 1996, 10:729-736.
49. Stempelj M., Kedinger M., Augenlicht L., Klampfer L. Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate. J. Biol. Chem. 2007, 282:9797-9804.
50. Tarrerias A.L., Millecamps M., Alloui A., Beaughard C., Kemeny J.L., Bourdu S., Bommelaer G., Eschalier A., Dapoigny M., Ardid D. Short-chain fatty acid enemas fail to decrease colonic hypersensitivity and inflammation in TNBS-induced colonic inflammation in rats. Pain 2002, 100:91-97.
51. Tedelind S., Westberg F., Kjerrulf M., Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J. Gastroenterol. 2007, 13:2826-2832.
52. Tone M., Powell M.J., Tone Y., Thompson S.A., Waldmann H. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J. Immunol. 2000, 165:286-291.
53. Van den Brande J.M., Braat H., van den Brink G.R., Versteeg H.H., Bauer C.A., Hoedemaeker I., van Montfrans C., Hommer D.W., Peppelenbosch M.P., van Deventer S.J. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. Gastroenterology 2003, 124:1774-1785.
54. Venkatraman A., Ramakrishna B.S., Shaji R.V., Kumar N.S., Pulimood A., Patra S. Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-kappaB. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285:G177-G184.
55. Wang J., Mahmud S.A., Bitterman P.B., Huo Y., Slungaard A. Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes. J. Biol. Chem. 2007, 282:28408-28418.
56. Weng M., Walker W.A., Sanderson I.R. Butyrate regulates the expression of pathogen-triggered IL-8 in intestinal epithelia. Pediatr. Res. 2007, 62:542-546.
57. Xaus J., Cardó M., Valledor A.F., Soler C., Lloberas J., Celada A. Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity 1999, 11:103-113.
58. Xaus J., Comalada M., Barrachina M., Herrero C., Goñalons E., Soler C., Lloberas J., Celada A. The expression of MHC class II genes in macrophages is cell cycle dependent. J. Immunol. 2000, 165:6364-6371.
59. Xaus J., Comalada M., Valledor A.F., Lloberas J., López-Soriano F., Argilés J.M., Bogdan C., Celada A. LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. Blood 2000, 95:3823-3831.
60. Xaus J., Comalada M., Valledor A.F., Cardó M., Herrero C., Soler C., Lloberas J., Celada A. Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis. Immunobiology 2001, 204:543-550.
61. Xaus J., Besalduch N., Comalada M., Marcoval J., Pujol R., Mañá J., Celada A. High expression of p21 Waf1 in sarcoid granulomas: a putative role for long-lasting inflammation. J. Leukocyte Biol. 2003, 74:295-301.